Table 1.
Demographic and Clinical Characteristics among GI Cancer Survivors.
| A. Main Dataset (2014 to 2021, Except for 2015) Total Weighted Study N = 229,428 Unweighted n = 3201 |
B. Subset of Main Dataset (2017, 2019, and 2021 with Diet Variables) Total Weighted Study N = 123,261 Unweighted n = 835 |
|||
|---|---|---|---|---|
| Year, n (%) | 229,428 | Years, n (%) | 123,261 | |
| 2014 | 12,576 (5.5) | 2014 | not included | |
| 2016 | 20,718 (9.0) | 2016 | not included | |
| 2017 | 16,870 (7.3) | 2017 | 57,933 (47) | |
| 2018 | 14,128 (6.1) | 2018 | not included | |
| 2019 | 196 (<0.1) | 2019 | 3,697 (3.0) | |
| 2020 | 141,212 (62) | 2020 | not included | |
| 2021 | 23,729 (10) | 2021 | 61,631 (50) | |
| Demographics (% otherwise specified) | ||||
| Age, median (Interquartile range, IQR) | 67 (58, 76) | 67 (58, 77) | ||
| Age group | 18–64 | 43% | 32% | |
| 65 or older | 57% | 68% | ||
| Sex | Male | 46% | 48% | |
| Female | 54% | 52% | ||
| Clinical Characteristics, n (%) | ||||
| Types of GI Cancer | Colorectal (intestine) | 72.5% | 77.1% | |
| Esophageal | 5.2% | 6% | ||
| Liver | 10% | 7.4% | ||
| Pancreatic | 5.1% | 4.6% | ||
| Stomach | 7.2% | 4.9% | ||
| Comorbidities, n (%) | ||||
| The participants self-reported if they had ever been told by a health professional that they had(“yes”/no”) | ||||
| Heart Attack (Yes) | 12% | 9.2% | ||
| Coronary Heart Disease (Yes) | 12% | 11% | ||
| Asthma (Yes) | 17% | 14% | ||
| Stroke (Yes) | 8.3% | 8.3% | ||
| Chronic Obstructive Pulmonary Disease (Yes) | 14.5% | 13.2% | ||
| Diabetes (Yes) | 51.3% | 54.9% | ||
| Chronic Arthritis (Yes) | 48.9% | 45.6% | ||
| Chronic Kidney Disease (Yes) | 8.4% | 11% | ||
| Overweight or obese per Body Mass Index (Yes) | 29.5% | 14% | ||
Note. Interquartile range, IQR.